giikorea.co.kr
 È¨ | ȸ»ç¼Ò°³ | ¸ÂÃãÇü ½ÃÀåÁ¶»ç | ±¹Á¦ÄÁÆÛ·±½º | ±Û·Î¹ú ÆÄÆ®³Ê | īŻ·Î±× | ¿¬¶ôó | Site Map |

Conference banner
  Page:   1   

Reports

ºñ¸¸Áõ : Ä¡·á¾à ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ¹× 2016³â±îÁöÀÇ ½ÃÀå ¿¹Ãø
Anti-Obesity - Drug Pipeline Analysis and Market Forecasts to 2016
  Pub Time : 2010/01
  Published by : GlobalData
ºñ¸¸Áõ ½ÃÀåÀÇ Ä¡·á¾à ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ¹× 2016³â±îÁöÀÇ ½ÃÀåÀ» ¿¹ÃøÇßÀ¸¸ç, ½ÃÀåÀÇ Æ¯Â¡À» ºñ·ÔÇÑ °æÇÕ, ÆÄÀÌÇÁ¶óÀÎ µîÀ» Æò°¡ºÐ¼®Çϰí Àå·¡ÀÇ ½ÃÀå °æÀï, ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸, °¨·® ¹× ½Ä»ç °ü¸® ½ÃÀå(ÀǾàǰ, ¼ö¼ú, ½ÄÀÌ¿ä¹ý)
Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
  Pub Time : 2009/12
  Published by : Kalorama Information
´ÙÀÌ¾îÆ® ½Äǰ ¹× À½·á, °¨·®¿ë ÀǾàǰ, ¿Ü°úÀû °³ÀÔ, °¨·® ÇÁ·Î±×·¥ µî ºÎ¹®º° µ¿ÇâÀ» Á¤¸®Çϰí, µ¿ ½ÃÀåÀÇ ÇâÈÄ Àü¸ÁÀ» ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ ¼ºÀÎ ºñ¸¸ ¹× ´ç´¢º´ ½ÃÀå : 2009³â 8¿ù
Adult Obesity and Diabetes - US - August 2009
  Pub Time : 2009/08
  Published by : Mintel International Group Ltd,
ºñ¸¸Áõ È®´ëÀÇ ¿øÀÎÀ» Á¶»ç ºÐ¼®Çϰí, ±â¾÷ÀÇ Àü·«, ºñ¸¸ ¼ÒºñÀÚÀÇ µ¿Çâ, ½Å»óǰ ¹× Àü·«¿¡ °üÇÑ Á¦¾È µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ ¹× À¯·´ÀÇ ºñ¸¸Áõ ¼ö¼ú Àåºñ ½ÃÀå
Bariatric (Obesity) Surgical Devices
  Pub Time : 2009/07
  Published by : Global Industry Analysts, Inc.
ºñ¸¸Áõ ¼ö¼ú Àåºñ¸¦ ÁÖÁ¦·Î ±â¼ú Çõ½Å, Á¦Ç° °³¹ß µîÀÇ ÇöÀç »óȲÀ» Á¶»çÇÏ°í ¹Ì±¹ ¹× À¯·´ °¢±¹ÀÇ µ¿Çâ°ú °úÁ¦, ÇâÈÄ Àü¸Á ºÐ¼® Á¤º¸, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸Áõ ½ÃÀå¿¡ ´ëÇÑ ¿¹Ãø
Obesity Market Forecast
  Pub Time : 2009/07
  Published by : Datamonitor
ºñ¸¸Áõ ½ÃÀåÀÇ Á¤·®Àû ¿¹Ãø, Ãâ½Ã ÀǾàǰ ¹× °³¹ß ¾àÁ¦¿¡ ´ëÇÑ Æò°¡, 2009³âºÎÅÍ 2018³â±îÁöÀÇ ÁÖ¿ä 7°³±¹ÀÇ ¸Å»ó ¿¹Ãø µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ °¨·® ¹× ½Ä»ç °ü¸® ½ÃÀå(2009¡­2014³â)
Global Weight Loss and Diet Management (2009 - 2014)
  Pub Time : 2009/07
  Published by : Markets and Markets
¼¼°èÀÇ °¨·® ¹× ½Ä»ç °ü¸® ½ÃÀå¿¡ °üÇØ »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, ½Äǰ¡¤´ëüǰ¡¤À½·á, ÀǾàǰ¡¤º¸ÃæÁ¦, Á¦Ç°, üÁß °ü¸® ¼­ºñ½º, ¼ººÐ µî ºÎ¹®º°·Î Á¤¸®ÇÏ¿© ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀϰú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸Áõ Ä¡·áÁ¦ ½ÃÀå
Pipeline and Commercial Insight: Obesity - The $11 billion market that never was
  Pub Time : 2009/07
  Published by : Datamonitor
¼¼°è ÁÖ¿ä 7°³±¹ ºñ¸¸Áõ ½ÃÀåÀÇ °³¿ä¿¡ ´ëÇØ Á¶»çÇϰí, ÁÖ¿ä ºê·£µå ºÐ¼®, ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼® µîÀ» ÀüÇØµå¸³´Ï´Ù.

Slentrol »ç·Ê¿¬±¸ : ÅëÇÕ PR Àü·«À» ÅëÇÑ Á¦Ç° ½ÃÆÇ Áö¿ø
Slentrol Case Study: Using Integrated PR Tactics to Support a Product Launch
  Pub Time : 2009/05
  Published by : Best Practices, LLC
Pfizer Animal Health»çÀÇ °³¿ë ºñ¸¸Ä¡·áÁ¦ ¡¸Slentrol¡¹ÀÇ ÆÇ¸Å¸¦ À§ÇÑ PR Àü·«¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÅÁ¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎÁöµµ Çâ»ó ¹× ¸Å»ó È®´ë¸¦ À§ÇÑ È¿°úÀûÀÎ PR Àü·« µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

´ç´¢º´¤ý´ë»çÁõÈıº¤ý½ÉÇ÷°üÁúȯ
Diabetes, Metabolic Syndrome and Cardiovascular Disease
  Pub Time : 2009/04
  Published by : Trimark Publications
´ç´¢º´ÀÇ °³¿ä¿Í ´ç´¢º´¿¡ µû¸¥ ÇÕº´Áõ, ´ç´¢º´ Ä¡·á¾àÀÇ ÇöÀç¿Í °³¹ß µ¿Çâ, ü¿ÜÁø´Ü¿¡ ÀÇÇÑ Áø´Ü, ½ÃÀå µ¿Çâ°ú °úÁ¦, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Áß±¹ÀÇ ºñ¸¸ Ä¡·áÁ¦ ½ÃÀå
Chinese Markets for Anti-Obesity Drugs
  Pub Time : 2009/04
  Published by : Asia Market Information & Development Co.
Áß±¹ÀÇ °æÁ¦ µ¿Çâ, ºñ¸¸ Ä¡·áÁ¦ ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä¤ý°ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå °æ·Î¤ýÁÖ¿ä ±â¾÷ µîÀ» »ó¼¼È÷ Á¶»çÇϰí 2003³â ¹× 2008³âÀÇ ½ÇÀû°ú 2013³â¤ý2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù.

¿µ±¹ÀÇ ºñ¸¸ »çÁ¤
Obesity - UK - March 2009
  Pub Time : 2009/03
  Published by : Mintel International Group Ltd,
±¤¹üÀ§ÇÏ°Ô ¹ÌÄ¡´Â ºñ¸¸ ¹®Á¦ÀÇ ÃËÁø¿äÀΰú ±× ¿µÇâ, ½Ä»ç¿Í °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ Ã¼Áß¿¡ ¹ÌÄ¡´Â º¯È­, ¼ÒºñÀÚ°¡ »ý°¢ÇÏ´Â ºñ¸¸ Áõ°¡ÀÇ ¿øÀÎ, ºñ¸¸¿¡ ´ëÇÑ ´ëÇ× ¹æ¹ý, ÁÖµµÀûÀÎ Á¶¾ð ±ÇÇÑ µî¿¡ ´ëÇÑ Á¶»ç ºÐ¼®À» ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ºñ¸¸Ä¡·á¾à ½ÃÀå
Anti-Obesity Drugs
  Pub Time : 2009/02
  Published by : Global Industry Analysts, Inc.
ºñ¸¸Ä¡·á¾à ½ÃÀåÀÇ °³¿ä, ºñ¸¸Ä¡·áÀÇ °³¿ä¿Í ÇÔ²² ÃÖ±ÙÀÇ ¾÷°è Ȱµ¿ ¹× °¢±¹ ½ÃÀåÀÇ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ºñ¸¸ Ä¡·á ½ÃÀå : 2009¡­2024³âÀÇ ºÐ¼® ¹× ¿¹Ãø
Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
  Pub Time : 2009/02
  Published by : Visiongain
¼¼°èÀÇ ºñ¸¸ Ä¡·áÁ¦ ½ÃÀåÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®Çϰí ÇöÀç ÁÖ¿ä ¾àÁ¦ÀÇ 2024³â±îÁö ¸ÅÃâ ¿¹Ãø, ½ÃÀåÀÇ SWOT ºÐ¼®, ÇöÀç °úÁ¦ ¹× ÇâÈÄ Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ °¨·® ¹× ´ÙÀÌ¾îÆ® ½ÃÀå (Á¦10ÆÇ)
The U.S. Weight Loss & Diet Control Market (10th Edition)
  Pub Time : 2009/02
  Published by : MarketData Enterprises, Inc.
¹Ì±¹ÀÇ ´ÙÀÌ¾îÆ® Àα¸ Åë°è ¹× ÇÁ·ÎÆÄÀÏ ºÐ¼®°ú ÇÔ²² ´ÙÀÌ¾îÆ® À½·á/½Äǰ, ÇÇÆ®´Ï½º Ŭ·´ÀÇ ´ÙÀÌ¾îÆ® ÇÁ·Î±×·¥, ´ÙÀÌ¾îÆ® °ü·Ã ºñÁî´Ï½º, ÅÃ¹è ¼­ºñ½º, º´¿ø ¹× Àü¹®°¡°¡ Á¦°øÇÏ´Â ´ÙÀÌ¾îÆ® Ç÷£, ºñ¸¸ ¿Ü°ú¼ö¼ú µîÀÇ ½ÃÀå ºÐ¼®¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ºñ¸¸ Ä¡·á¾à ½ÃÀå
Booming Global Obesity Drug Market
  Pub Time : 2008/12
  Published by : RNCOS E-Services Pvt. Ltd.
¼¼°è ºñ¸¸ Ä¡·á¾à ½ÃÀåÀÇ °ú°Å/ÇöÀç ½ÇÀû ¹× Àå·¡ µ¿ÇâÀÇ ºÐ¼®, Ãâ½Ã¿Ï·á/°³¹ß´Ü°èÀÇ °¢Á¾ Ä¡·á¾à Æò°¡ ¹× ÁÖ¿ä Á¦Ç°ÀÇ Àå·¡ Àü¸ÁÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸ Ä¡·á¾à ÆÄÀÌÇÁ¶óÀÎ : º¹ÇÕÁúȯÀÇ Ä¡·á¹ý °³¹ß
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
  Pub Time : 2008/09
  Published by : Insight Pharma Reports
ºñ¸¸ Ä¡·á¸¦ À§ÇÑ Á¦Ç° ÆÄÀÌÇÁ¶óÀÎ, »õ·Î¿î Ä¡·á¹ýÀÇ ¿ä°Ç°ú ÇöÀçÀÇ ºñ¸¸ Ä¡·á¾à, ÇâÈÄÀÇ °úÁ¦ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¿µ±¹ ¹× EUÀÇ ºñ¸¸Ä¡·á ÀǾàǰ ½ÃÀå
Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environmen
  Pub Time : 2008/07
  Published by : Business Insights
ºñ¸¸Ä¡·áÀÇ Ãֽе¿Çâ, ÇöÀçÀÇ Ãâ½Ã Á¦Ç° µ¿Çâ°ú ÀÓ»ó ½ÇÇèÁßÀÎ ¾àÁ¦, ÇâÈÄ ¸Å»ó ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Lipitor(¸®ÇÇÅç) ½ÃÀå ºÐ¼®°ú ¿¹Ãø : 2007¡­2012³â ¹× 2017³â, 2023³â
Lipitor Market analysis and forecasts Report, 2007-2012, 2017 & 2023
  Pub Time : 2008/04
  Published by : Visiongain
PfizerÀÇ Lipitor ¼º°ø ¿äÀΰú ƯÇã ½ÇÈ¿¿¡ µû¸¥ ¿µÇâ, Áö¿ªº° ½ÃÀå µ¿Çâ, °³¹ßÁßÀÎ ¾àǰ µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Target Product Profiles : ºñ¸¸Áõ - ´õ¿í °¨·® È¿°ú°¡ ÀÖ´Â Ä¡·á
Target Product Profiles: Physician Insights on Key Attributes - Obesity, A therapy that is more effective than orlistat at inducing weight loss for the treatment of obesity
  Pub Time : 2008/03
  Published by : Decision Resources, Inc.
ºñ¸¸ Ä¡·á¿¡ »ç¿ëµÇ´Â orlistatº¸´Ù °¨·®¿¡ À¯È¿ÇÑ Ä¡·á ¹æ¹ý¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí ÁÖ¿ä ¹ÌÃæÁ· ¿ä±¸»çÇ×À» ÃæÁ·½ÃŰ´Â ¾àÁ¦ÀÇ ÀáÀ缺¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

Àü¼¼°èÀÇ ºñ¸¸ ÀÓ»ó°ü¸® ½ÃÀå : 2007-2015³â
Worldwide Market for the Clinical Management of Obesity, 2007-2015
  Pub Time : 2007/09
  Published by : MedMarket Diligence
ºñ¸¸ ÀÓ»ó°ü¸® Á¦Ç° ¹× ±â¼ú¿¡ °üÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ¿¹ÃøÀ» ¼öÇàÇÏ¿©, ºñ¸¸ ȯÀÚÀα¸ µ¿Çâ, ¹Ì±¹/À¯·´ µîÁöÀÇ µ¿Çâ, ºñ¸¸ÀÇ ¿Ü°úÀû ¾îÇÁ·ÎÄ¡, ¾àÁ¦ ¿ä¹ý, OTC Ä¡·á µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸Ä¡·á¸¦ À§ÇÑ ½Å¾à°³¹ß µ¿Çâ
Obesity Drug Discoveries: what the future holds
  Pub Time : 2007/08
  Published by : Espicom Business Intelligence
ºñ¸¸ÀÇ °³¿ä ¹× Ä¡·á½ÃÀå µ¿Çâ, ½Å¾à°³¹ß µ¿Çâ ¹× ÀÓ»ó½ÇÇèÁßÀÎ ¾àÁ¦°³¿ä, Àå·¡ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸Ä¡·á µ¿Çâ : 2007-2012³â
Anti-Obesity Treatments 2007-2012 - A blockbuster target market
  Pub Time : 2007/07
  Published by : Visiongain
ºñ¸¸Ä¡·á¾à ½ÃÀåÀÇ ÀÇ·áÁ¾»çÀÚ, Çмúȸ, »ê¾÷°èÀÇ Àü¹®°¡ ÀǰßÀ» ¼öÁýÇÏ¿©, SWOT ºÐ¼®, À繫 ¿¹Ãø µî Æ÷°ýÀû Á¶»ç °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.

¿µ±¹ÀÇ ¾Æµ¿ºñ¸¸
Childhood Obesity - UK - June 2007
  Pub Time : 2007/06
  Published by : Mintel International Group Ltd,
¸é¹ÐÇÑ ¼ÒºñÀÚÁ¶»ç¸¦ ÅëÇØ ¿µ±¹ÀÇ ¾Æµ¿ ºñ¸¸À² Áõ°¡¿¡ ÀÇÇÑ À½½Äǰ¾÷°èÀÇ ¿µÇâ¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ ´ÙÀÌ¾îÆ® ½ÃÀå(Á¦9ÆÇ)
The U.S. Weight Loss & Diet Control Market (9th Edition)
  Pub Time : 2007/04
  Published by : MarketData Enterprises, Inc.
¹Ì±¹ÀÇ ´ÙÀÌ¾îÆ® Àα¸ Åë°è ¹× ÇÁ·ÎÆÄÀÏ ºÐ¼®À» ºñ·ÔÇÏ¿© ´ÙÀÌ¾îÆ® À½·á¤ýÀΰø°¨¹Ì·á µîÀÇ ½Äǰ, ÇコŬ·´¿¡ ÀÇÇÑ ´ÙÀÌ¾îÆ® ÇÁ·Î±×·¥, ´ÙÀÌ¾îÆ® °ü·Ã üÀÎ/ÇÁ·£Â÷ÀÌÁî ºñÁî´Ï½º, ÅÃ¹è ¼­ºñ½º, º´¿ø ¹× Àü¹®°¡°¡ Á¦°øÇÏ´Â ´ÙÀÌ¾îÆ® Ç÷£, ´ÙÀÌ¾îÆ® ¸ñÀû ¿Ü°ú ¼ö¼ú µîÀÇ ½ÃÀå¿¡ °üÇÏ¿© Á¶»çºÐ¼®Çϰí, °¢Á¾ ½ÃÀå µ¥ÀÌÅÍ ¹× ¼­ºñ½º ³»¿ë, °ü·Ã ±â¾÷ ÇÁ·ÎÆÄÀÏ, ÀÌ¿ëÀÚ ÇÁ·ÎÆÄÀÏ µîÀ» Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ´ç´¢º´ ¹× ´ç´¢ÇÕº´Áõ Ä¡·á½ÃÀåÀÇ µ¿Çâ : Á¦ 3 ÆÇ
Diabetes and Diabetic Complications: Major World Markets, 3rd Ed.
  Pub Time : 2007/03
  Published by : Kalorama Information
2016³â±îÁöÀÇ Á¦ 1 Çü, Á¦ 2 Çü ´ç´¢º´ÀÇ ±¹°¡º° ½ÃÀå¿¹Ãø, ºÐ¾ßº° ½ÃÀå±Ô¸ð, ½ÅÁ¦Ç° ¹× ±â¼ú°³¹ß µ¿Çâ, Áö¿ªº° º¯µ¿ ¹× ÁÖ¿ä±â¾÷ÀÇ ÇÁ·ÎÆÄÀϰú °æÇÕµ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ Ã¼Áß °ü¸® Á¦Ç° ½ÃÀå
Weight Control Products - US - March 2007
  Pub Time : 2007/03
  Published by : Mintel International Group Ltd,
¹Ì±¹ÀÇ ºñ¸¸Áõ Áõ°¡¿Í ¼ÒºñÀÚÀÇ °Ç°­°úÀÇ Àΰú °ü°è°¡ üÁß °ü¸® Á¦Ç° ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ, ½ÃÀåÀÌ Á÷¸éÇÑ ´Ù¾çÇÑ °úÁ¦ÀÇ º»Áú ¹× ¾÷°è¿¡ ¹ÌÄ¡´Â Á÷Á¢ÀûÀÎ ¿µÇâ, üÁß °ü¸® Á¦Ç°¿¡ ´ëÇÑ »çȸÀû ÀνÄÀÌ °¡Àå ÁÁÀº ¾È³»¹ý, Áö±Ý±îÁö ºÒÈ®½ÇÇÑ Ã¤ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ¾î ¿Â ¼±Àü ¹æ¹ý ÀÌ¿ÜÀÇ º¸´Ù È¿°úÀûÀÎ ±¤°í¸¦ ÅëÇÑ °æÀï, ¼ÒºñÀÚÀÇ ´ÙÀÌ¾îÆ® ¹ß»ý·ü ¹× OTC ÀǾàǰÀÇ ÀÌ¿ë, ƯÁ¤ Á¦Ç°¿¡ ´ëÇÑ ÀǽÄ, ´Ü±â°£ÀÇ °¨·® ¹æ¹ý µîÀÇ ¼ÒºñÀÚ µ¿Çâ µîÀ» Á¦°øÇÕ´Ï´Ù.

ºñ¸¸ Ä¡·á¾à ½ÃÀ壺»óȯ µ¿ÇâÀÌ ¹ÌÄ¡´Â ¿µÇâ
Commercial and Pipeline Perspectives: Obesity - Lack of Reimbursement Limits Market Potential
  Pub Time : 2006/12
  Published by : Datamonitor
ºñ¸¸ Ä¡·á¾à ½ÃÀå ÇöȲ ¹× 2015³â±îÁöÀÇ °³¹ß µ¿Çâ, ¹Ì´Þ¼º ¼ö¿ä, 2015³â±îÁö ÁÖ¿ä Á¦Ç°ÀÇ ¸ÅÃâ ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ º£¸®¾ÆÆ®¸¯(ºñ¸¸Ä¡·á) ±â±â ½ÃÀå : 2006³â
US Markets for Bariatric Equipment and Devices 2006
  Pub Time : 2006/10
  Published by : Millennium Research Group
¹Ì±¹ÀÇ º£¸®¾ÆÆ®¸¯ ±â±â ½ÃÀå °³¿ä¿Í º£¸®¾ÆÆ®¸¯ ħ´ë, ¼ö¼ú´ë ¹× ºÎ¼Ó±â±â, ¸®ÇÁÆ®, ÈÙü¾î, À§¹êµå, º¹°­°æ ±â±â µî¿¡ ´ëÇÑ ½ÃÀ嵿Çâ°ú ÇâÈÄ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ Ç׺ñ¸¸¾à½ÃÀå
U.S. Anti-obesity Prescription Markets
  Pub Time : 2006/09
  Published by : Frost & Sullivan
¹Ì±¹ÀÇ Ç׺ñ¸¸¾à ½ÃÀåÀÇ °³¿ä¿Í ¼öÀÍ ±¸Á¶, Á¦Ç° ºÐ¼®, °æÀï ±â¾÷ ÇÁ·ÎÆÄÀϰú 2002³âºÎÅÍ 2012³â¿¡ °ÉÄ£ ½ÃÀå ¿¹Ãø, Àü·«Àû Á¦¾ðµî¿¡ ´ëÇØ ÀüÇØ µå¸³´Ï´Ù.

ºñ¸¸: ¼¼°èÀÇ ÀǾàǰ ¹× ¿Ü°úÀû Ä¡·á ½ÃÀåÀÇ µ¿Çâ
Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment
  Pub Time : 2006/06
  Published by : Kalorama Information
º» º¸°í¼­´Â ¹Ì±¹ ¹× ¼¼°èÀÇ ºñ¸¸ Ä¡·á¾à ¹× ¿Ü°ú Ä¡·á ½ÃÀåÀÇ ±Ô¸ð¿Í È®´ë ¿¹Ãø, °æÇÕ ½ÃÀå Á¡À¯À², ºñ¸¸¿¡ °üÇÑ ¿ªÇÐ µ¥ÀÌÅÍ, 50°¡Áö°¡ ³Ñ´Â °³¹ßÁß¿¡ ÀÖ´Â ¾àÁ¦ÀÇ »ó¼¼ µ¿Çâ ¹× ÁÖ¿ä ±â¾÷ 14»çÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÀÓ»óÂ÷¿øÀÇ ºñ¸¸ °ü¸®
Clinical Management of Obesity
  Pub Time : 2006/06
  Published by : Technical Insights, Inc.
ÇöÀç ½ÃÀå¿¡¼­ Åë¿ëµÇ°í ÀÖ´Â ´Ù¾çÇÑ °¨·® Á¦Ç° ¹× Ä¡·á¹ý¿¡ ´ëÇÑ °³¿ä, °¨·®À» À§ÇÑ ´ÙÀÌ¾îÆ® ¿ä¹ý, »ýȰ ½À°ü ±³Á¤, ¾à¹° ¿ä¹ý, ºñ¸¸ ¼ö¼ú ¹× ÀÇ·á ±â±â µî¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.

¸ÞŸº¼¸¯ ½Åµå·Ò(Metabolic Syndrome, ´ë»ç ÁõÈıº) ½ÃÀå
Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
  Pub Time : 2006/04
  Published by : Datamonitor
¸ÞŸº¼¸¯ ½Åµå·Ò(´ë»ç ÁõÈıº)ÀÇ ÀÌȯÀ²°ú Áõ»ó, ÁõÈıº ¹× Ä¡·á¿¡ ´ëÇÑ ÀÇ»çµéÀÇ ÀνÄ, ±âÁ¸ ¾àÁ¦ÀÇ °¡´É¼º, ÀÌ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇ׸ñ µî¿¡ ´ëÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ºñ¸¸ Ä¡·á ±â±â ¹× ¿Ü°ú ¼ö¼ú ±â±â - ½ÃÀå Àü·« º¸°í¼­
Bariatric (Obesity) Care Equipment & Surgical Devices Worldwide - A Market Strategy Report
  Pub Time : 2006/02
  Published by : Marketstrat, Inc.
ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ºñ¸¸ Ä¡·á ±â±â ¹× ¿Ü°ú ¼ö¼ú ±â±â ½ÃÀåÀÇ ¿¹Ãø, ½ÃÀå ÃßÁø ¿äÀÎ ¹× Àå¾Ö ¿äÀÎ, KPPI±×¸®µå, °æÀï °ñÁ¶, SRCE°ñÁ¶, ÁÖ¿ä ½ÃÀå ÆÄ¶ó¹ÌÅÍ µîÀÇ ½ÃÀå °³¿ä¿Í 90°³ ÀÌ»óÀÇ ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

¸ÞŸº¼¸¯ ½Åµå·Ò(Metabolic Syndrome, ´ë»ç ÁõÈıº)ÀÇ È¿°úÀû °ü¸®¿¡ ´ëÇÑ À庮
Barriers to Effective Management of Metabolic Syndrome
  Pub Time : 2005/12
  Published by : Decision Resources, Inc.
¸ÞŸº¼¸¯ ½Åµå·ÒÀÇ Á¤ÀÇ¿¡ ´ëÇÑ ÇÕÀÇ ºÎÁ·¿¡¼­ ±âÀÎÇÏ´Â ¹®Á¦ ¹× ÇâÈÄ Àü¸Á µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

ºñ¸¸Áõ Ä¡·á¿Í Ä¡·á±â±âÀÇ µ¿Çâ Á¶»ç: 2005³â
Bariatric Procedure and Product Trends Survey Report 2005
  Pub Time : 2005/07
  Published by : Millennium Research Group
ºñ¸¸Áõ ȯÀÚ °³¿ä¿Í Ä¡·áÀÇ Á¾·ù, Àü¿ë±â±âÀÇ ÀÌ¿ë µ¿Çâ, ºñ¸¸Áõ Ä¡·á±â±â ±¸ÀÔ¿¡ ´ëÇÑ À庮µî¿¡ ´ëÇØ ´ë·« ¾Æ·¡¿Í °°Àº ±¸¼ºÀ¸·Î ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ ´ë»çÁõÈıº Ä¡·áÁ¦ ½ÃÀåÀÇ ¿¹Ãø
Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast
  Pub Time : 2005/01
  Published by : Insight Pharma Reports
º» º¸°í¼­´Â ºñ¸¸, Áö¹æÁú ´ë»çÀÌ»ó, 2Çü ´ç´¢º´, °íÇ÷¾ÐÀÇ ½ÃÀå¾à ¹× °³¹ß ÁßÀÎ ÀÇ¾à Æò°¡, ÃÖ±ÙÀÇ ¶óÀÌÇÁ½ºÅ¸ÀϰúÀÇ »óÈ£ °ü°è, °³¹ß ÁßÀÎ 13°³ ÀǾàǰÀÇ ÀåÁ¡°ú ¾àÁ¡, ÇâÈÄ 15³â°£ ¹Ì±¹ ½ÃÀå ¿¹Ãø µîÀÇ Á¤º¸¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, ´ë·« ¾Æ·¡¿Í °°Àº ±¸¼ºÀ¸·Î ÀüÇØ µå¸³´Ï´Ù.

ºñ¸¸ ÀÓ»ó°ü¸®
Products, Technologies and Markets in the U.S. and Europe in the Clinical Management of Obesity
  Pub Time : 2004/09
  Published by : MedMarket Diligence

ÁÖ¿ä ÀÇ¾à ºÐ¼®
Commercial and Pipeline Perspectives: Obesity - Super-sized Epidemic
  Pub Time : 2004/07
  Published by : Datamonitor

¾î¸°ÀÌ¿Í ºñ¸¸
Kids and Obesity: Health issues and ethical food and drinks marketing to children under 16 years old
  Pub Time : 2004/07
  Published by : Business Insights

Ç÷°ü Áúȯ
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
  Pub Time : 2004/02
  Published by : Business Insights

ºñ¸¸Ä¡·áÁ¦Ç°°ú ¼­ºñ½º ½ÃÀå
Weight Control Products & Services
  Pub Time : 2004/02
  Published by : The Freedonia Group

ÁöÁú´ë»ç ÀÌ»ó ¾àÀÇ »ó¾÷ ¸ñÇ¥ ¿¹Ãø
Commercial Perspectives: Anti-dyslipidemics - A tale of two launches
  Pub Time : 2004/01
  Published by : Datamonitor

Áö¹æÁú ´ë»çÀÌ»ó Ä¡·áÀÇ Ãֽе¿Çâ:ÀûÁ¤°ú È¥ÇÕ Ä¡·á
Stakeholder Insight: Dyslipidemia - Titration versus Combination Therapy
  Pub Time : 2004/01
  Published by : Datamonitor

¹Ì±¹ÀÇ ½ÃÆÇ ´ÙÀÌ¾îÆ® º¸Á¶ ½Äǰ ½ÃÀå
The U.S. Market for OTC Diet Aids
  Pub Time : 2004/01
  Published by : Kalorama Information

¿Â¶óÀÎ ´ÙÀ̾îÅÍ ¸®¼­Ä¡ : 2009³â Á¦3»çºÐ±â
Online Dieter Research - Quarterly Report 3th Quarter 2009
  Pub Time :
  Published by : MarketData Enterprises, Inc.
MarketData°¡ ¿î¿µÇÏ´Â ´ÙÀÌ¾îÆ® »çÀÌÆ® "BestDietForMe.com"ÀÇ ÀÌ¿ëÀÚ¿¡°Ô 50 Ç׸ñÀÇ ¾ÓÄÉÀÌÆ®¸¦ ½Ç½ÃÇϰí, »çºÐ±âº° Áý°è °á°ú·ÎºÎÅÍ ´ÙÀÌ¾îÆ® ½ÃÀåÀÇ µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

  Page:   1   


| Home | Contact | E-mailing | About GII | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§| Site Map |
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç
Tel:02-2025-2992, Fax:02-2025-2993, E-mail :
(C) Copyright 2009, Global Information, Inc. All rights reserved.